Major Ingredients

Each 5 ml lnjectable solution contains Etoposide USP 100mg

Major Functionality

Etoposide is indicated in the management of the following neoplasms: Small Cell Lung Cancer: Etoposide is indicated in combination with other approved chemotherapeutic agents as first line treatment in patients with small cell lung cancer. Refractory Testicular Tumors: Etoposide is also indicated in combination therapy with other approved chemotherapeutic agents in patients with refractory testicular tumors who have already received appropriate surgical, chemotherapeutic, and radio therapeutic therapy

Manufacture Information

Drug International Limited was incorporated under the Registrar of Joint Stock Companies in 1974 as a Private Limited Company. The company commenced formulation and production in 1983 and emerged as a pioneer in Bangladesh for adding a state of the art oral solid dosage plant. Since inception, Drug International Limited's primary objective has been to meet guidelines provided by major global regulatory bodies such as the World Health Organization Good Manufacturing Practices (WHO cGMP) guidelines.